Find clinical trials for Prostate Cancer in Barcelona, CT
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Prostate Cancer trials near Barcelona, CT, ESP:
This is a Phase 1/2, open-label, randomized, dose finding and dose expansion study to evaluate the safety, preliminary efficacy, and PK of gedatolisi...
Phase 1, Phase 2
Barcelona, Spain and 12 other locations
primary trial objective is to demonstrate that ODM-201 produces prostate-specific antigen (PSA) response rates at 24 weeks (defined as ≥80% ...
Phase 2
Badalona, Spain and 12 other locations
The main purpose of this study is to assess the safety and tolerability of AZD0516 as monotherapy and/or in combination with other anti-cancer...
Phase 1, Phase 2
Barcelona, Spain and 51 other locations
ANDROMEDA is a first-in-human, Phase I/II, open-label, multicenter study of AZD9750 in participants with metastatic prostate cancer...
Phase 1, Phase 2
Barcelona, Spain and 17 other locations
Metastatic prostate cancer is an incurable disease that typically spreads beyond the prostate. The standard of care is to ...
Phase 2, Phase 3
Barcelona, Spain and 29 other locations
The study will be conducted in 4 parts and will commence with dose escalation of VIR-5500 as a monotherapy (Part 1), followed by combination escalati...
Phase 1
Barcelona, Spain and 9 other locations
Effects of Saruparib (AZD5305) Alone, Darolutamide Alone, and in Combination Given Prior to Radical Prostatectomy in Men with Newly Diagnosed Prostate...
Phase 1
Barcelona, Spain and 18 other locations
This study is being conducted to learn more about the safety, tolerability, and effectiveness of an experimental treatment for metastatic prostate...
Phase 1, Phase 2
Barcelona, Spain and 24 other locations
and abiraterone in patients with metastatic castration-resistant prostate cancer (mCRPC) who have received no prior cytotoxic chemo ...
Phase 3
Barcelona, Spain and 131 other locations
The overall aim of the trial is to evaluate the safety, tolerability, and pharmacokinetics (PK) of AMG 509 (monotherapy and in combination with abira...
Phase 1
Barcelona, Catalonia, Spain and 57 other locations
Clinical trials
Research sites
Resources
Legal